Dae Ho Lee
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Viral-associated cancers and disorders
- Lung Cancer Research Studies
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 64
- Cancer Immunotherapy and Biomarkers 20
- Lung Cancer Research Studies 12
- Viral-associated cancers and disorders 12
- Peptidase Inhibition and Analysis 7
-
- Lymphoma Diagnosis and Treatment 37
- Co-authors
- Kilwon Cho (12 shared papers)Cheolwon Suh (57 shared papers)Sang‐Hoon Lee (5 shared papers)Seung Goo Lee (3 shared papers)Jooryung Huh (24 shared papers)Ho Sun Lim (5 shared papers)Sang‐We Kim (34 shared papers)Ji‐Youn Han (12 shared papers)
- Journals
- Journal of Clinical Oncology (20 papers)Annals of Hematology (9 papers)Blood (8 papers)Journal of Thoracic Oncology (5 papers)Investigational New Drugs (4 papers)
- Partner nations
- South KoreaUnited StatesSpain
In The Last Decade
Dae Ho Lee
205 papers receiving 6.4k citations
Dae Ho Lee's Hit Papers
Peers
Comparison fields: 5 of 163
- Oncology 1.9k
- Pathology and Forensic Medicine 1.1k
- Surfaces, Coatings and Films 435
- Immunology 719
- Endocrinology, Diabetes and Metabolism 378
Countries citing papers authored by Dae Ho Lee
This map shows the geographic impact of Dae Ho Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dae Ho Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dae Ho Lee more than expected).
Fields of papers citing papers by Dae Ho Lee
This network shows the impact of papers produced by Dae Ho Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dae Ho Lee. The network helps show where Dae Ho Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Dae Ho Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 211 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 477 | |
| 2 | Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study Hit paper breakdown → | 2022 | 313 |
| 3 | 2010 | 278 | |
| 4 | 2006 | 236 | |
| 5 | 2010 | 215 | |
| 6 | 2004 | 200 | |
| 7 | 2020 | 191 | |
| 8 | 2020 | 163 | |
| 9 | 2005 | 114 | |
| 10 | 2009 | 111 | |
| 11 | 2008 | 109 | |
| 12 | 2009 | 107 | |
| 13 | 2010 | 106 | |
| 14 | 2013 | 101 | |
| 15 | 2017 | 100 | |
| 16 | 2010 | 95 | |
| 17 | 2012 | 84 | |
| 18 | 2008 | 75 | |
| 19 | 2011 | 70 | |
| 20 | 2009 | 69 |
About Dae Ho Lee
Dae Ho Lee is a scholar working on Oncology, Pathology and Forensic Medicine, Molecular Biology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism, having authored 211 papers that have together received 6.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (37 papers), Cancer Immunotherapy and Biomarkers (20 papers), Lung Cancer Research Studies (12 papers), Viral-associated cancers and disorders (12 papers), Lung Cancer Treatments and Mutations (8 papers), Metabolism, Diabetes, and Cancer (7 papers), Immunotherapy and Immune Responses (7 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Oncology (1.9k citations), Pathology and Forensic Medicine (1.1k citations), Surfaces, Coatings and Films (435 citations), Immunology (719 citations) and Endocrinology, Diabetes and Metabolism (378 citations). Dae Ho Lee has collaborated with scholars based in South Korea, United States and Spain. Frequent co-authors include Kilwon Cho, Cheolwon Suh, Sang‐Hoon Lee, Seung Goo Lee, Jooryung Huh, Ho Sun Lim, Sang‐We Kim, Ji‐Youn Han, Joong Tark Han and Chang Y. Ryu. Their work appears in journals such as Journal of Clinical Oncology, Annals of Hematology, Blood, Journal of Thoracic Oncology and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.